Karyopharm Therapeutics | Capitale Ordinario

Ordinary Share Capital Cambiamento Data
Amgen USD 32.75B 152M 2023-09
AstraZeneca USD 387M 0 2023-09
Avrobio USD 4K 0 2023-09
GlaxoSmithKline GBP 1.35B 0 2023-09
Pfizer USD 478M 0 2023-09
Regeneron Pharmaceuticals USD 102K 0 2023-09
Roche Holding CHF 107M 0 2023-06
Takeda JPY 1.68T 92M 2023-09
TG Therapeutics USD 151K 0 2023-09
Ultragenyx Pharmaceutical USD 72K 1000 2023-09
Xencor USD 611K 4K 2023-12



Karyopharm Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.